Filspari Interactions
There are 594 drugs known to interact with Filspari (sparsentan), along with 3 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 92 are major, 497 are moderate, and 5 are minor.
- View all 594 medications that may interact with Filspari
- View Filspari alcohol/food interactions (3)
- View Filspari disease interactions (3)
Most frequently checked interactions
View interaction reports for Filspari (sparsentan) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- albuterol
- allopurinol
- amlodipine
- amlodipine / atorvastatin
- amphetamine
- Anoro Ellipta (umeclidinium / vilanterol)
- Aspirin Low Strength (aspirin)
- atorvastatin
- benazepril
- carvedilol
- chlorthalidone
- colchicine
- famotidine
- Farxiga (dapagliflozin)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- folic acid
- Juluca (dolutegravir / rilpivirine)
- labetalol
- loratadine
- metformin
- omeprazole
- prednisone
- sodium bicarbonate
- spironolactone
- Tamiflu (oseltamivir)
- Uloric (febuxostat)
- valsartan
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
Filspari alcohol/food interactions
There are 3 alcohol/food interactions with Filspari (sparsentan).
Filspari disease interactions
There are 3 disease interactions with Filspari (sparsentan) which include:
Report options
QR code containing a link to this page
More about Filspari (sparsentan)
- Filspari consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous cardiovascular agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
